Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E D Bird

Showing results (111-120 of 150) with videos related to

Pageof 15
Sort By:
Annals of Neurology|September 1, 1986
Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's diseaseM F Beal, M F Mazurek, G K Chattha, et al.
Journal of Neuropathology and Experimental Neurology|January 1, 1987
Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's diseaseR J Ferrante, N W Kowall, M F Beal, et al.
Journal of Psychiatric Research|January 1, 1984
Dexamethasone increases plasma free dopamine in manA J Rothschild, P J Langlais, A F Schatzberg, et al.
Journal of the Neurological Sciences|May 1, 1995
Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferasesD Jauch, E M Urbańska, P Guidetti, et al.
Biochemical and Biophysical Research Communications|September 14, 1990
Basic fibroblast growth factor in Alzheimer's diseaseE G Stopa, A M Gonzalez, R Chorsky, et al.
Brain Research|November 12, 1976
Alterations of brain neurotransmitter receptor binding in Huntington's choreaS J Enna, J P Bennett, D B Bylund, et al.
Journal of the Neurological Sciences|March 1, 1992
Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortexM F Beal, W R Matson, E Storey, et al.
Life Sciences|October 15, 1977
Alterations in dopaminergic receptors in Huntington's diseaseT D Reisine, J Z Fields, L Z Stern, et al.
Journal of Neuropathology and Experimental Neurology|November 1, 1985
Neuropathological classification of Huntington's diseaseJ P Vonsattel, R H Myers, T J Stevens, et al.
Lancet (London, England)|October 25, 1980
Dopamine receptors and schizophrenia: drug effect or illness?A V Mackay, E D Bird, E G Spokes, et al.
Pageof 15

Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
Annals of Neurology|September 1, 1986
Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's diseaseM F Beal, M F Mazurek, G K Chattha, et al.
Journal of Neuropathology and Experimental Neurology|January 1, 1987
Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's diseaseR J Ferrante, N W Kowall, M F Beal, et al.
Journal of Psychiatric Research|January 1, 1984
Dexamethasone increases plasma free dopamine in manA J Rothschild, P J Langlais, A F Schatzberg, et al.
Journal of the Neurological Sciences|May 1, 1995
Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferasesD Jauch, E M Urbańska, P Guidetti, et al.
Biochemical and Biophysical Research Communications|September 14, 1990
Basic fibroblast growth factor in Alzheimer's diseaseE G Stopa, A M Gonzalez, R Chorsky, et al.
Brain Research|November 12, 1976
Alterations of brain neurotransmitter receptor binding in Huntington's choreaS J Enna, J P Bennett, D B Bylund, et al.
Journal of the Neurological Sciences|March 1, 1992
Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortexM F Beal, W R Matson, E Storey, et al.
Life Sciences|October 15, 1977
Alterations in dopaminergic receptors in Huntington's diseaseT D Reisine, J Z Fields, L Z Stern, et al.
Journal of Neuropathology and Experimental Neurology|November 1, 1985
Neuropathological classification of Huntington's diseaseJ P Vonsattel, R H Myers, T J Stevens, et al.
Lancet (London, England)|October 25, 1980
Dopamine receptors and schizophrenia: drug effect or illness?A V Mackay, E D Bird, E G Spokes, et al.
Pageof 15